Global Poliovirus Vaccine Market Research Report 2026(Status and Outlook)
Polio vaccines are vaccines used to prevent poliomyelitis (polio).The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The global Poliovirus Vaccine market size was estimated at USD 767.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 4.40% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Poliovirus Vaccine market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Poliovirus Vaccine market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Poliovirus Vaccine market.
Global Poliovirus Vaccine Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Sanofi
GSK
Bibcol
Serum Institute
Tiantan Biological
IMBCA
Panacea Biotec Ltd
Bio-Med
Halfkin Bio-Pharmaceuticals
Market Segmentation (by Type)
Inactivated Polio Vaccine (IPV)
Oral Polio Vaccine (OPV)
Market Segmentation (by Application)
Public
Private
Geographic Segmentation
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Poliovirus Vaccine Market
Overview of the regional outlook of the Poliovirus Vaccine Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Poliovirus Vaccine Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Poliovirus Vaccine, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
The global Poliovirus Vaccine market size was estimated at USD 767.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 4.40% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Poliovirus Vaccine market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Poliovirus Vaccine market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Poliovirus Vaccine market.
Global Poliovirus Vaccine Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Sanofi
GSK
Bibcol
Serum Institute
Tiantan Biological
IMBCA
Panacea Biotec Ltd
Bio-Med
Halfkin Bio-Pharmaceuticals
Market Segmentation (by Type)
Inactivated Polio Vaccine (IPV)
Oral Polio Vaccine (OPV)
Market Segmentation (by Application)
Public
Private
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Poliovirus Vaccine Market
Overview of the regional outlook of the Poliovirus Vaccine Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Poliovirus Vaccine Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Poliovirus Vaccine, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Poliovirus Vaccine
1.2 Key Market Segments
1.2.1 Poliovirus Vaccine Segment by Type
1.2.2 Poliovirus Vaccine Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 POLIOVIRUS VACCINE MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Poliovirus Vaccine Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Poliovirus Vaccine Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 POLIOVIRUS VACCINE MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Poliovirus Vaccine Product Life Cycle
3.3 Global Poliovirus Vaccine Sales by Manufacturers (2020-2025)
3.4 Global Poliovirus Vaccine Revenue Market Share by Manufacturers (2020-2025)
3.5 Poliovirus Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Poliovirus Vaccine Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Poliovirus Vaccine Market Competitive Situation and Trends
3.8.1 Poliovirus Vaccine Market Concentration Rate
3.8.2 Global 5 and 10 Largest Poliovirus Vaccine Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 POLIOVIRUS VACCINE INDUSTRY CHAIN ANALYSIS
4.1 Poliovirus Vaccine Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF POLIOVIRUS VACCINE MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Poliovirus Vaccine Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Poliovirus Vaccine Market
5.7 ESG Ratings of Leading Companies
6 POLIOVIRUS VACCINE MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Poliovirus Vaccine Sales Market Share by Type (2020-2025)
6.3 Global Poliovirus Vaccine Market Size by Type (2020-2025)
6.4 Global Poliovirus Vaccine Price by Type (2020-2025)
7 POLIOVIRUS VACCINE MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Poliovirus Vaccine Market Sales by Application (2020-2025)
7.3 Global Poliovirus Vaccine Market Size (M USD) by Application (2020-2025)
7.4 Global Poliovirus Vaccine Sales Growth Rate by Application (2020-2025)
8 POLIOVIRUS VACCINE MARKET SALES BY REGION
8.1 Global Poliovirus Vaccine Sales by Region
8.1.1 Global Poliovirus Vaccine Sales by Region
8.1.2 Global Poliovirus Vaccine Sales Market Share by Region
8.2 Global Poliovirus Vaccine Market Size by Region
8.2.1 Global Poliovirus Vaccine Market Size by Region
8.2.2 Global Poliovirus Vaccine Market Size by Region
8.3 North America
8.3.1 North America Poliovirus Vaccine Sales by Country
8.3.2 North America Poliovirus Vaccine Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Poliovirus Vaccine Sales by Country
8.4.2 Europe Poliovirus Vaccine Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Poliovirus Vaccine Sales by Region
8.5.2 Asia Pacific Poliovirus Vaccine Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Poliovirus Vaccine Sales by Country
8.6.2 South America Poliovirus Vaccine Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Poliovirus Vaccine Sales by Region
8.7.2 Middle East and Africa Poliovirus Vaccine Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 POLIOVIRUS VACCINE MARKET PRODUCTION BY REGION
9.1 Global Production of Poliovirus Vaccine by Region(2020-2025)
9.2 Global Poliovirus Vaccine Revenue Market Share by Region (2020-2025)
9.3 Global Poliovirus Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Poliovirus Vaccine Production
9.4.1 North America Poliovirus Vaccine Production Growth Rate (2020-2025)
9.4.2 North America Poliovirus Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Poliovirus Vaccine Production
9.5.1 Europe Poliovirus Vaccine Production Growth Rate (2020-2025)
9.5.2 Europe Poliovirus Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Poliovirus Vaccine Production (2020-2025)
9.6.1 Japan Poliovirus Vaccine Production Growth Rate (2020-2025)
9.6.2 Japan Poliovirus Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Poliovirus Vaccine Production (2020-2025)
9.7.1 China Poliovirus Vaccine Production Growth Rate (2020-2025)
9.7.2 China Poliovirus Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Sanofi
10.1.1 Sanofi Basic Information
10.1.2 Sanofi Poliovirus Vaccine Product Overview
10.1.3 Sanofi Poliovirus Vaccine Product Market Performance
10.1.4 Sanofi Business Overview
10.1.5 Sanofi SWOT Analysis
10.1.6 Sanofi Recent Developments
10.2 GSK
10.2.1 GSK Basic Information
10.2.2 GSK Poliovirus Vaccine Product Overview
10.2.3 GSK Poliovirus Vaccine Product Market Performance
10.2.4 GSK Business Overview
10.2.5 GSK SWOT Analysis
10.2.6 GSK Recent Developments
10.3 Bibcol
10.3.1 Bibcol Basic Information
10.3.2 Bibcol Poliovirus Vaccine Product Overview
10.3.3 Bibcol Poliovirus Vaccine Product Market Performance
10.3.4 Bibcol Business Overview
10.3.5 Bibcol SWOT Analysis
10.3.6 Bibcol Recent Developments
10.4 Serum Institute
10.4.1 Serum Institute Basic Information
10.4.2 Serum Institute Poliovirus Vaccine Product Overview
10.4.3 Serum Institute Poliovirus Vaccine Product Market Performance
10.4.4 Serum Institute Business Overview
10.4.5 Serum Institute Recent Developments
10.5 Tiantan Biological
10.5.1 Tiantan Biological Basic Information
10.5.2 Tiantan Biological Poliovirus Vaccine Product Overview
10.5.3 Tiantan Biological Poliovirus Vaccine Product Market Performance
10.5.4 Tiantan Biological Business Overview
10.5.5 Tiantan Biological Recent Developments
10.6 IMBCA
10.6.1 IMBCA Basic Information
10.6.2 IMBCA Poliovirus Vaccine Product Overview
10.6.3 IMBCA Poliovirus Vaccine Product Market Performance
10.6.4 IMBCA Business Overview
10.6.5 IMBCA Recent Developments
10.7 Panacea Biotec Ltd
10.7.1 Panacea Biotec Ltd Basic Information
10.7.2 Panacea Biotec Ltd Poliovirus Vaccine Product Overview
10.7.3 Panacea Biotec Ltd Poliovirus Vaccine Product Market Performance
10.7.4 Panacea Biotec Ltd Business Overview
10.7.5 Panacea Biotec Ltd Recent Developments
10.8 Bio-Med
10.8.1 Bio-Med Basic Information
10.8.2 Bio-Med Poliovirus Vaccine Product Overview
10.8.3 Bio-Med Poliovirus Vaccine Product Market Performance
10.8.4 Bio-Med Business Overview
10.8.5 Bio-Med Recent Developments
10.9 Halfkin Bio-Pharmaceuticals
10.9.1 Halfkin Bio-Pharmaceuticals Basic Information
10.9.2 Halfkin Bio-Pharmaceuticals Poliovirus Vaccine Product Overview
10.9.3 Halfkin Bio-Pharmaceuticals Poliovirus Vaccine Product Market Performance
10.9.4 Halfkin Bio-Pharmaceuticals Business Overview
10.9.5 Halfkin Bio-Pharmaceuticals Recent Developments
11 POLIOVIRUS VACCINE MARKET FORECAST BY REGION
11.1 Global Poliovirus Vaccine Market Size Forecast
11.2 Global Poliovirus Vaccine Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Poliovirus Vaccine Market Size Forecast by Country
11.2.3 Asia Pacific Poliovirus Vaccine Market Size Forecast by Region
11.2.4 South America Poliovirus Vaccine Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Poliovirus Vaccine by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Poliovirus Vaccine Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Poliovirus Vaccine by Type (2026-2035)
12.1.2 Global Poliovirus Vaccine Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Poliovirus Vaccine by Type (2026-2035)
12.2 Global Poliovirus Vaccine Market Forecast by Application (2026-2035)
12.2.1 Global Poliovirus Vaccine Sales (K MT) Forecast by Application
12.2.2 Global Poliovirus Vaccine Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Poliovirus Vaccine
1.2 Key Market Segments
1.2.1 Poliovirus Vaccine Segment by Type
1.2.2 Poliovirus Vaccine Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 POLIOVIRUS VACCINE MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Poliovirus Vaccine Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Poliovirus Vaccine Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 POLIOVIRUS VACCINE MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Poliovirus Vaccine Product Life Cycle
3.3 Global Poliovirus Vaccine Sales by Manufacturers (2020-2025)
3.4 Global Poliovirus Vaccine Revenue Market Share by Manufacturers (2020-2025)
3.5 Poliovirus Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Poliovirus Vaccine Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Poliovirus Vaccine Market Competitive Situation and Trends
3.8.1 Poliovirus Vaccine Market Concentration Rate
3.8.2 Global 5 and 10 Largest Poliovirus Vaccine Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 POLIOVIRUS VACCINE INDUSTRY CHAIN ANALYSIS
4.1 Poliovirus Vaccine Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF POLIOVIRUS VACCINE MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Poliovirus Vaccine Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Poliovirus Vaccine Market
5.7 ESG Ratings of Leading Companies
6 POLIOVIRUS VACCINE MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Poliovirus Vaccine Sales Market Share by Type (2020-2025)
6.3 Global Poliovirus Vaccine Market Size by Type (2020-2025)
6.4 Global Poliovirus Vaccine Price by Type (2020-2025)
7 POLIOVIRUS VACCINE MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Poliovirus Vaccine Market Sales by Application (2020-2025)
7.3 Global Poliovirus Vaccine Market Size (M USD) by Application (2020-2025)
7.4 Global Poliovirus Vaccine Sales Growth Rate by Application (2020-2025)
8 POLIOVIRUS VACCINE MARKET SALES BY REGION
8.1 Global Poliovirus Vaccine Sales by Region
8.1.1 Global Poliovirus Vaccine Sales by Region
8.1.2 Global Poliovirus Vaccine Sales Market Share by Region
8.2 Global Poliovirus Vaccine Market Size by Region
8.2.1 Global Poliovirus Vaccine Market Size by Region
8.2.2 Global Poliovirus Vaccine Market Size by Region
8.3 North America
8.3.1 North America Poliovirus Vaccine Sales by Country
8.3.2 North America Poliovirus Vaccine Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Poliovirus Vaccine Sales by Country
8.4.2 Europe Poliovirus Vaccine Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Poliovirus Vaccine Sales by Region
8.5.2 Asia Pacific Poliovirus Vaccine Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Poliovirus Vaccine Sales by Country
8.6.2 South America Poliovirus Vaccine Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Poliovirus Vaccine Sales by Region
8.7.2 Middle East and Africa Poliovirus Vaccine Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 POLIOVIRUS VACCINE MARKET PRODUCTION BY REGION
9.1 Global Production of Poliovirus Vaccine by Region(2020-2025)
9.2 Global Poliovirus Vaccine Revenue Market Share by Region (2020-2025)
9.3 Global Poliovirus Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Poliovirus Vaccine Production
9.4.1 North America Poliovirus Vaccine Production Growth Rate (2020-2025)
9.4.2 North America Poliovirus Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Poliovirus Vaccine Production
9.5.1 Europe Poliovirus Vaccine Production Growth Rate (2020-2025)
9.5.2 Europe Poliovirus Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Poliovirus Vaccine Production (2020-2025)
9.6.1 Japan Poliovirus Vaccine Production Growth Rate (2020-2025)
9.6.2 Japan Poliovirus Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Poliovirus Vaccine Production (2020-2025)
9.7.1 China Poliovirus Vaccine Production Growth Rate (2020-2025)
9.7.2 China Poliovirus Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Sanofi
10.1.1 Sanofi Basic Information
10.1.2 Sanofi Poliovirus Vaccine Product Overview
10.1.3 Sanofi Poliovirus Vaccine Product Market Performance
10.1.4 Sanofi Business Overview
10.1.5 Sanofi SWOT Analysis
10.1.6 Sanofi Recent Developments
10.2 GSK
10.2.1 GSK Basic Information
10.2.2 GSK Poliovirus Vaccine Product Overview
10.2.3 GSK Poliovirus Vaccine Product Market Performance
10.2.4 GSK Business Overview
10.2.5 GSK SWOT Analysis
10.2.6 GSK Recent Developments
10.3 Bibcol
10.3.1 Bibcol Basic Information
10.3.2 Bibcol Poliovirus Vaccine Product Overview
10.3.3 Bibcol Poliovirus Vaccine Product Market Performance
10.3.4 Bibcol Business Overview
10.3.5 Bibcol SWOT Analysis
10.3.6 Bibcol Recent Developments
10.4 Serum Institute
10.4.1 Serum Institute Basic Information
10.4.2 Serum Institute Poliovirus Vaccine Product Overview
10.4.3 Serum Institute Poliovirus Vaccine Product Market Performance
10.4.4 Serum Institute Business Overview
10.4.5 Serum Institute Recent Developments
10.5 Tiantan Biological
10.5.1 Tiantan Biological Basic Information
10.5.2 Tiantan Biological Poliovirus Vaccine Product Overview
10.5.3 Tiantan Biological Poliovirus Vaccine Product Market Performance
10.5.4 Tiantan Biological Business Overview
10.5.5 Tiantan Biological Recent Developments
10.6 IMBCA
10.6.1 IMBCA Basic Information
10.6.2 IMBCA Poliovirus Vaccine Product Overview
10.6.3 IMBCA Poliovirus Vaccine Product Market Performance
10.6.4 IMBCA Business Overview
10.6.5 IMBCA Recent Developments
10.7 Panacea Biotec Ltd
10.7.1 Panacea Biotec Ltd Basic Information
10.7.2 Panacea Biotec Ltd Poliovirus Vaccine Product Overview
10.7.3 Panacea Biotec Ltd Poliovirus Vaccine Product Market Performance
10.7.4 Panacea Biotec Ltd Business Overview
10.7.5 Panacea Biotec Ltd Recent Developments
10.8 Bio-Med
10.8.1 Bio-Med Basic Information
10.8.2 Bio-Med Poliovirus Vaccine Product Overview
10.8.3 Bio-Med Poliovirus Vaccine Product Market Performance
10.8.4 Bio-Med Business Overview
10.8.5 Bio-Med Recent Developments
10.9 Halfkin Bio-Pharmaceuticals
10.9.1 Halfkin Bio-Pharmaceuticals Basic Information
10.9.2 Halfkin Bio-Pharmaceuticals Poliovirus Vaccine Product Overview
10.9.3 Halfkin Bio-Pharmaceuticals Poliovirus Vaccine Product Market Performance
10.9.4 Halfkin Bio-Pharmaceuticals Business Overview
10.9.5 Halfkin Bio-Pharmaceuticals Recent Developments
11 POLIOVIRUS VACCINE MARKET FORECAST BY REGION
11.1 Global Poliovirus Vaccine Market Size Forecast
11.2 Global Poliovirus Vaccine Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Poliovirus Vaccine Market Size Forecast by Country
11.2.3 Asia Pacific Poliovirus Vaccine Market Size Forecast by Region
11.2.4 South America Poliovirus Vaccine Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Poliovirus Vaccine by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Poliovirus Vaccine Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Poliovirus Vaccine by Type (2026-2035)
12.1.2 Global Poliovirus Vaccine Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Poliovirus Vaccine by Type (2026-2035)
12.2 Global Poliovirus Vaccine Market Forecast by Application (2026-2035)
12.2.1 Global Poliovirus Vaccine Sales (K MT) Forecast by Application
12.2.2 Global Poliovirus Vaccine Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Poliovirus Vaccine Market Size by Type (M USD)
Table 4. Global Poliovirus Vaccine Market Size by Application
Table 5. Poliovirus Vaccine Market Size Comparison by Region (M USD)
Table 6. Global Poliovirus Vaccine Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Poliovirus Vaccine Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Poliovirus Vaccine Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Poliovirus Vaccine Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Poliovirus Vaccine as of 2025)
Table 11. Global Market Poliovirus Vaccine Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Poliovirus Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Poliovirus Vaccine Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Poliovirus Vaccine Sales by Type (K MT)
Table 27. Global Poliovirus Vaccine Market Size by Type (M USD)
Table 28. Global Poliovirus Vaccine Sales (K MT) by Type (2020-2025)
Table 29. Global Poliovirus Vaccine Sales Market Share by Type (2020-2025)
Table 30. Global Poliovirus Vaccine Market Size (M USD) by Type (2020-2025)
Table 31. Global Poliovirus Vaccine Market Share by Type (2020-2025)
Table 32. Global Poliovirus Vaccine Price (USD/KG) by Type (2020-2025)
Table 33. Global Poliovirus Vaccine Sales (K MT) by Application
Table 34. Global Poliovirus Vaccine Market Size by Application
Table 35. Global Poliovirus Vaccine Sales by Application (2020-2025) & (K MT)
Table 36. Global Poliovirus Vaccine Sales Market Share by Application (2020-2025)
Table 37. Global Poliovirus Vaccine Market Size by Application (2020-2025) & (M USD)
Table 38. Global Poliovirus Vaccine Market Share by Application (2020-2025)
Table 39. Global Poliovirus Vaccine Sales Growth Rate by Application (2020-2025)
Table 40. Global Poliovirus Vaccine Sales by Region (2020-2025) & (K MT)
Table 41. Global Poliovirus Vaccine Sales Market Share by Region (2020-2025)
Table 42. Global Poliovirus Vaccine Market Size by Region (2020-2025) & (M USD)
Table 43. Global Poliovirus Vaccine Market Size by Region (2020-2025)
Table 44. North America Poliovirus Vaccine Sales by Country (2020-2025) & (K MT)
Table 45. North America Poliovirus Vaccine Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Poliovirus Vaccine Sales by Country (2020-2025) & (K MT)
Table 47. Europe Poliovirus Vaccine Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Poliovirus Vaccine Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Poliovirus Vaccine Market Size by Region (2020-2025) & (M USD)
Table 50. South America Poliovirus Vaccine Sales by Country (2020-2025) & (K MT)
Table 51. South America Poliovirus Vaccine Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Poliovirus Vaccine Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Poliovirus Vaccine Market Size by Region (2020-2025) & (M USD)
Table 54. Global Poliovirus Vaccine Production (K MT) by Region(2020-2025)
Table 55. Global Poliovirus Vaccine Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Poliovirus Vaccine Revenue Market Share by Region (2020-2025)
Table 57. Global Poliovirus Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Poliovirus Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Poliovirus Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Poliovirus Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Poliovirus Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. Sanofi Basic Information
Table 63. Sanofi Poliovirus Vaccine Product Overview
Table 64. Sanofi Poliovirus Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. Sanofi Business Overview
Table 66. Sanofi SWOT Analysis
Table 67. Sanofi Recent Developments
Table 68. GSK Basic Information
Table 69. GSK Poliovirus Vaccine Product Overview
Table 70. GSK Poliovirus Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. GSK Business Overview
Table 72. GSK SWOT Analysis
Table 73. GSK Recent Developments
Table 74. Bibcol Basic Information
Table 75. Bibcol Poliovirus Vaccine Product Overview
Table 76. Bibcol Poliovirus Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. Bibcol Business Overview
Table 78. Bibcol SWOT Analysis
Table 79. Bibcol Recent Developments
Table 80. Serum Institute Basic Information
Table 81. Serum Institute Poliovirus Vaccine Product Overview
Table 82. Serum Institute Poliovirus Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. Serum Institute Business Overview
Table 84. Serum Institute Recent Developments
Table 85. Tiantan Biological Basic Information
Table 86. Tiantan Biological Poliovirus Vaccine Product Overview
Table 87. Tiantan Biological Poliovirus Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. Tiantan Biological Business Overview
Table 89. Tiantan Biological Recent Developments
Table 90. IMBCA Basic Information
Table 91. IMBCA Poliovirus Vaccine Product Overview
Table 92. IMBCA Poliovirus Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. IMBCA Business Overview
Table 94. IMBCA Recent Developments
Table 95. Panacea Biotec Ltd Basic Information
Table 96. Panacea Biotec Ltd Poliovirus Vaccine Product Overview
Table 97. Panacea Biotec Ltd Poliovirus Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. Panacea Biotec Ltd Business Overview
Table 99. Panacea Biotec Ltd Recent Developments
Table 100. Bio-Med Basic Information
Table 101. Bio-Med Poliovirus Vaccine Product Overview
Table 102. Bio-Med Poliovirus Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. Bio-Med Business Overview
Table 104. Bio-Med Recent Developments
Table 105. Halfkin Bio-Pharmaceuticals Basic Information
Table 106. Halfkin Bio-Pharmaceuticals Poliovirus Vaccine Product Overview
Table 107. Halfkin Bio-Pharmaceuticals Poliovirus Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 108. Halfkin Bio-Pharmaceuticals Business Overview
Table 109. Halfkin Bio-Pharmaceuticals Recent Developments
Table 110. Global Poliovirus Vaccine Sales Forecast by Region (2026-2035) & (K MT)
Table 111. Global Poliovirus Vaccine Market Size Forecast by Region (2026-2035) & (M USD)
Table 112. North America Poliovirus Vaccine Sales Forecast by Country (2026-2035) & (K MT)
Table 113. North America Poliovirus Vaccine Market Size Forecast by Country (2026-2035) & (M USD)
Table 114. Europe Poliovirus Vaccine Sales Forecast by Country (2026-2035) & (K MT)
Table 115. Europe Poliovirus Vaccine Market Size Forecast by Country (2026-2035) & (M USD)
Table 116. Asia Pacific Poliovirus Vaccine Sales Forecast by Region (2026-2035) & (K MT)
Table 117. Asia Pacific Poliovirus Vaccine Market Size Forecast by Region (2026-2035) & (M USD)
Table 118. South America Poliovirus Vaccine Sales Forecast by Country (2026-2035) & (K MT)
Table 119. South America Poliovirus Vaccine Market Size Forecast by Country (2026-2035) & (M USD)
Table 120. Middle East and Africa Poliovirus Vaccine Sales Forecast by Country (2026-2035) & (Units)
Table 121. Middle East and Africa Poliovirus Vaccine Market Size Forecast by Country (2026-2035) & (M USD)
Table 122. Global Poliovirus Vaccine Sales Forecast by Type (2026-2035) & (K MT)
Table 123. Global Poliovirus Vaccine Market Size Forecast by Type (2026-2035) & (M USD)
Table 124. Global Poliovirus Vaccine Price Forecast by Type (2026-2035) & (USD/KG)
Table 125. Global Poliovirus Vaccine Sales (K MT) Forecast by Application (2026-2035)
Table 126. Global Poliovirus Vaccine Market Size Forecast by Application (2026-2035) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Poliovirus Vaccine Market Size by Type (M USD)
Table 4. Global Poliovirus Vaccine Market Size by Application
Table 5. Poliovirus Vaccine Market Size Comparison by Region (M USD)
Table 6. Global Poliovirus Vaccine Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Poliovirus Vaccine Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Poliovirus Vaccine Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Poliovirus Vaccine Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Poliovirus Vaccine as of 2025)
Table 11. Global Market Poliovirus Vaccine Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Poliovirus Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Poliovirus Vaccine Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Poliovirus Vaccine Sales by Type (K MT)
Table 27. Global Poliovirus Vaccine Market Size by Type (M USD)
Table 28. Global Poliovirus Vaccine Sales (K MT) by Type (2020-2025)
Table 29. Global Poliovirus Vaccine Sales Market Share by Type (2020-2025)
Table 30. Global Poliovirus Vaccine Market Size (M USD) by Type (2020-2025)
Table 31. Global Poliovirus Vaccine Market Share by Type (2020-2025)
Table 32. Global Poliovirus Vaccine Price (USD/KG) by Type (2020-2025)
Table 33. Global Poliovirus Vaccine Sales (K MT) by Application
Table 34. Global Poliovirus Vaccine Market Size by Application
Table 35. Global Poliovirus Vaccine Sales by Application (2020-2025) & (K MT)
Table 36. Global Poliovirus Vaccine Sales Market Share by Application (2020-2025)
Table 37. Global Poliovirus Vaccine Market Size by Application (2020-2025) & (M USD)
Table 38. Global Poliovirus Vaccine Market Share by Application (2020-2025)
Table 39. Global Poliovirus Vaccine Sales Growth Rate by Application (2020-2025)
Table 40. Global Poliovirus Vaccine Sales by Region (2020-2025) & (K MT)
Table 41. Global Poliovirus Vaccine Sales Market Share by Region (2020-2025)
Table 42. Global Poliovirus Vaccine Market Size by Region (2020-2025) & (M USD)
Table 43. Global Poliovirus Vaccine Market Size by Region (2020-2025)
Table 44. North America Poliovirus Vaccine Sales by Country (2020-2025) & (K MT)
Table 45. North America Poliovirus Vaccine Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Poliovirus Vaccine Sales by Country (2020-2025) & (K MT)
Table 47. Europe Poliovirus Vaccine Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Poliovirus Vaccine Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Poliovirus Vaccine Market Size by Region (2020-2025) & (M USD)
Table 50. South America Poliovirus Vaccine Sales by Country (2020-2025) & (K MT)
Table 51. South America Poliovirus Vaccine Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Poliovirus Vaccine Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Poliovirus Vaccine Market Size by Region (2020-2025) & (M USD)
Table 54. Global Poliovirus Vaccine Production (K MT) by Region(2020-2025)
Table 55. Global Poliovirus Vaccine Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Poliovirus Vaccine Revenue Market Share by Region (2020-2025)
Table 57. Global Poliovirus Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Poliovirus Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Poliovirus Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Poliovirus Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Poliovirus Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. Sanofi Basic Information
Table 63. Sanofi Poliovirus Vaccine Product Overview
Table 64. Sanofi Poliovirus Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. Sanofi Business Overview
Table 66. Sanofi SWOT Analysis
Table 67. Sanofi Recent Developments
Table 68. GSK Basic Information
Table 69. GSK Poliovirus Vaccine Product Overview
Table 70. GSK Poliovirus Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. GSK Business Overview
Table 72. GSK SWOT Analysis
Table 73. GSK Recent Developments
Table 74. Bibcol Basic Information
Table 75. Bibcol Poliovirus Vaccine Product Overview
Table 76. Bibcol Poliovirus Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. Bibcol Business Overview
Table 78. Bibcol SWOT Analysis
Table 79. Bibcol Recent Developments
Table 80. Serum Institute Basic Information
Table 81. Serum Institute Poliovirus Vaccine Product Overview
Table 82. Serum Institute Poliovirus Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. Serum Institute Business Overview
Table 84. Serum Institute Recent Developments
Table 85. Tiantan Biological Basic Information
Table 86. Tiantan Biological Poliovirus Vaccine Product Overview
Table 87. Tiantan Biological Poliovirus Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. Tiantan Biological Business Overview
Table 89. Tiantan Biological Recent Developments
Table 90. IMBCA Basic Information
Table 91. IMBCA Poliovirus Vaccine Product Overview
Table 92. IMBCA Poliovirus Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. IMBCA Business Overview
Table 94. IMBCA Recent Developments
Table 95. Panacea Biotec Ltd Basic Information
Table 96. Panacea Biotec Ltd Poliovirus Vaccine Product Overview
Table 97. Panacea Biotec Ltd Poliovirus Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. Panacea Biotec Ltd Business Overview
Table 99. Panacea Biotec Ltd Recent Developments
Table 100. Bio-Med Basic Information
Table 101. Bio-Med Poliovirus Vaccine Product Overview
Table 102. Bio-Med Poliovirus Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. Bio-Med Business Overview
Table 104. Bio-Med Recent Developments
Table 105. Halfkin Bio-Pharmaceuticals Basic Information
Table 106. Halfkin Bio-Pharmaceuticals Poliovirus Vaccine Product Overview
Table 107. Halfkin Bio-Pharmaceuticals Poliovirus Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 108. Halfkin Bio-Pharmaceuticals Business Overview
Table 109. Halfkin Bio-Pharmaceuticals Recent Developments
Table 110. Global Poliovirus Vaccine Sales Forecast by Region (2026-2035) & (K MT)
Table 111. Global Poliovirus Vaccine Market Size Forecast by Region (2026-2035) & (M USD)
Table 112. North America Poliovirus Vaccine Sales Forecast by Country (2026-2035) & (K MT)
Table 113. North America Poliovirus Vaccine Market Size Forecast by Country (2026-2035) & (M USD)
Table 114. Europe Poliovirus Vaccine Sales Forecast by Country (2026-2035) & (K MT)
Table 115. Europe Poliovirus Vaccine Market Size Forecast by Country (2026-2035) & (M USD)
Table 116. Asia Pacific Poliovirus Vaccine Sales Forecast by Region (2026-2035) & (K MT)
Table 117. Asia Pacific Poliovirus Vaccine Market Size Forecast by Region (2026-2035) & (M USD)
Table 118. South America Poliovirus Vaccine Sales Forecast by Country (2026-2035) & (K MT)
Table 119. South America Poliovirus Vaccine Market Size Forecast by Country (2026-2035) & (M USD)
Table 120. Middle East and Africa Poliovirus Vaccine Sales Forecast by Country (2026-2035) & (Units)
Table 121. Middle East and Africa Poliovirus Vaccine Market Size Forecast by Country (2026-2035) & (M USD)
Table 122. Global Poliovirus Vaccine Sales Forecast by Type (2026-2035) & (K MT)
Table 123. Global Poliovirus Vaccine Market Size Forecast by Type (2026-2035) & (M USD)
Table 124. Global Poliovirus Vaccine Price Forecast by Type (2026-2035) & (USD/KG)
Table 125. Global Poliovirus Vaccine Sales (K MT) Forecast by Application (2026-2035)
Table 126. Global Poliovirus Vaccine Market Size Forecast by Application (2026-2035) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Poliovirus Vaccine
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Poliovirus Vaccine Market Size (M USD), 2025-2035
Figure 5. Global Poliovirus Vaccine Market Size (M USD) (2020-2035)
Figure 6. Global Poliovirus Vaccine Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Poliovirus Vaccine Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Poliovirus Vaccine Product Life Cycle
Figure 13. Poliovirus Vaccine Sales Share by Manufacturers in 2025
Figure 14. Global Poliovirus Vaccine Revenue Share by Manufacturers in 2025
Figure 15. Poliovirus Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Poliovirus Vaccine Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Poliovirus Vaccine Revenue in 2025
Figure 18. Industry Chain Map of Poliovirus Vaccine
Figure 19. Global Poliovirus Vaccine Market PEST Analysis
Figure 20. Global Poliovirus Vaccine Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Poliovirus Vaccine Market Share by Type
Figure 27. Sales Market Share of Poliovirus Vaccine by Type (2020-2025)
Figure 28. Sales Market Share of Poliovirus Vaccine by Type in 2025
Figure 29. Market Share of Poliovirus Vaccine by Type (2020-2025)
Figure 30. Market Share of Poliovirus Vaccine by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Poliovirus Vaccine Market Share by Application
Figure 33. Global Poliovirus Vaccine Sales Market Share by Application (2020-2025)
Figure 34. Global Poliovirus Vaccine Sales Market Share by Application in 2025
Figure 35. Global Poliovirus Vaccine Market Share by Application (2020-2025)
Figure 36. Global Poliovirus Vaccine Market Share by Application in 2025
Figure 37. Global Poliovirus Vaccine Sales Growth Rate by Application (2020-2025)
Figure 38. Global Poliovirus Vaccine Sales Market Share by Region (2020-2025)
Figure 39. Global Poliovirus Vaccine Market Size by Region (2020-2025)
Figure 40. North America Poliovirus Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Poliovirus Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Poliovirus Vaccine Sales Market Share by Country in 2024
Figure 43. North America Poliovirus Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Poliovirus Vaccine Market Size by Country in 2024
Figure 45. U.S. Poliovirus Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Poliovirus Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Poliovirus Vaccine Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Poliovirus Vaccine Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Poliovirus Vaccine Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Poliovirus Vaccine Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Poliovirus Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Poliovirus Vaccine Sales Market Share by Country in 2024
Figure 53. Europe Poliovirus Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Poliovirus Vaccine Market Size by Country in 2024
Figure 55. Germany Poliovirus Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Poliovirus Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Poliovirus Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Poliovirus Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Poliovirus Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Poliovirus Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Poliovirus Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Poliovirus Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Poliovirus Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Poliovirus Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Poliovirus Vaccine Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Poliovirus Vaccine Sales Market Share by Region in 2024
Figure 67. Asia Pacific Poliovirus Vaccine Market Size by Region in 2024
Figure 68. China Poliovirus Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Poliovirus Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Poliovirus Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Poliovirus Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Poliovirus Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Poliovirus Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Poliovirus Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Poliovirus Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Poliovirus Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Poliovirus Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Poliovirus Vaccine Sales and Growth Rate (K MT)
Figure 79. South America Poliovirus Vaccine Sales Market Share by Country in 2024
Figure 80. South America Poliovirus Vaccine Market Size and Growth Rate (M USD)
Figure 81. South America Poliovirus Vaccine Market Size by Country in 2024
Figure 82. Brazil Poliovirus Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Poliovirus Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Poliovirus Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Poliovirus Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Poliovirus Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Poliovirus Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Poliovirus Vaccine Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Poliovirus Vaccine Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Poliovirus Vaccine Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Poliovirus Vaccine Market Size by Region in 2024
Figure 92. Saudi Arabia Poliovirus Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Poliovirus Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Poliovirus Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Poliovirus Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Poliovirus Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Poliovirus Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Poliovirus Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Poliovirus Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Poliovirus Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Poliovirus Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Poliovirus Vaccine Production Market Share by Region (2020-2025)
Figure 103. North America Poliovirus Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Poliovirus Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Poliovirus Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 106. China Poliovirus Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Poliovirus Vaccine Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Poliovirus Vaccine Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Poliovirus Vaccine Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Poliovirus Vaccine Market Share Forecast by Type (2026-2035)
Figure 111. Global Poliovirus Vaccine Sales Forecast by Application (2026-2035)
Figure 112. Global Poliovirus Vaccine Market Share Forecast by Application (2026-2035)
Figure 1. Product Picture of Poliovirus Vaccine
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Poliovirus Vaccine Market Size (M USD), 2025-2035
Figure 5. Global Poliovirus Vaccine Market Size (M USD) (2020-2035)
Figure 6. Global Poliovirus Vaccine Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Poliovirus Vaccine Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Poliovirus Vaccine Product Life Cycle
Figure 13. Poliovirus Vaccine Sales Share by Manufacturers in 2025
Figure 14. Global Poliovirus Vaccine Revenue Share by Manufacturers in 2025
Figure 15. Poliovirus Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Poliovirus Vaccine Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Poliovirus Vaccine Revenue in 2025
Figure 18. Industry Chain Map of Poliovirus Vaccine
Figure 19. Global Poliovirus Vaccine Market PEST Analysis
Figure 20. Global Poliovirus Vaccine Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Poliovirus Vaccine Market Share by Type
Figure 27. Sales Market Share of Poliovirus Vaccine by Type (2020-2025)
Figure 28. Sales Market Share of Poliovirus Vaccine by Type in 2025
Figure 29. Market Share of Poliovirus Vaccine by Type (2020-2025)
Figure 30. Market Share of Poliovirus Vaccine by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Poliovirus Vaccine Market Share by Application
Figure 33. Global Poliovirus Vaccine Sales Market Share by Application (2020-2025)
Figure 34. Global Poliovirus Vaccine Sales Market Share by Application in 2025
Figure 35. Global Poliovirus Vaccine Market Share by Application (2020-2025)
Figure 36. Global Poliovirus Vaccine Market Share by Application in 2025
Figure 37. Global Poliovirus Vaccine Sales Growth Rate by Application (2020-2025)
Figure 38. Global Poliovirus Vaccine Sales Market Share by Region (2020-2025)
Figure 39. Global Poliovirus Vaccine Market Size by Region (2020-2025)
Figure 40. North America Poliovirus Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Poliovirus Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Poliovirus Vaccine Sales Market Share by Country in 2024
Figure 43. North America Poliovirus Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Poliovirus Vaccine Market Size by Country in 2024
Figure 45. U.S. Poliovirus Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Poliovirus Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Poliovirus Vaccine Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Poliovirus Vaccine Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Poliovirus Vaccine Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Poliovirus Vaccine Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Poliovirus Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Poliovirus Vaccine Sales Market Share by Country in 2024
Figure 53. Europe Poliovirus Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Poliovirus Vaccine Market Size by Country in 2024
Figure 55. Germany Poliovirus Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Poliovirus Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Poliovirus Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Poliovirus Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Poliovirus Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Poliovirus Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Poliovirus Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Poliovirus Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Poliovirus Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Poliovirus Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Poliovirus Vaccine Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Poliovirus Vaccine Sales Market Share by Region in 2024
Figure 67. Asia Pacific Poliovirus Vaccine Market Size by Region in 2024
Figure 68. China Poliovirus Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Poliovirus Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Poliovirus Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Poliovirus Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Poliovirus Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Poliovirus Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Poliovirus Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Poliovirus Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Poliovirus Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Poliovirus Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Poliovirus Vaccine Sales and Growth Rate (K MT)
Figure 79. South America Poliovirus Vaccine Sales Market Share by Country in 2024
Figure 80. South America Poliovirus Vaccine Market Size and Growth Rate (M USD)
Figure 81. South America Poliovirus Vaccine Market Size by Country in 2024
Figure 82. Brazil Poliovirus Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Poliovirus Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Poliovirus Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Poliovirus Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Poliovirus Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Poliovirus Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Poliovirus Vaccine Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Poliovirus Vaccine Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Poliovirus Vaccine Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Poliovirus Vaccine Market Size by Region in 2024
Figure 92. Saudi Arabia Poliovirus Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Poliovirus Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Poliovirus Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Poliovirus Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Poliovirus Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Poliovirus Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Poliovirus Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Poliovirus Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Poliovirus Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Poliovirus Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Poliovirus Vaccine Production Market Share by Region (2020-2025)
Figure 103. North America Poliovirus Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Poliovirus Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Poliovirus Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 106. China Poliovirus Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Poliovirus Vaccine Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Poliovirus Vaccine Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Poliovirus Vaccine Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Poliovirus Vaccine Market Share Forecast by Type (2026-2035)
Figure 111. Global Poliovirus Vaccine Sales Forecast by Application (2026-2035)
Figure 112. Global Poliovirus Vaccine Market Share Forecast by Application (2026-2035)
